Next Article in Journal
Advocate-BREAST80+: A Comprehensive Patient and Advocate-Led Study to Enhance Breast Cancer Care Delivery and Patient-Centered Research in Women Aged ≥80 Years
Previous Article in Journal
Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis
Previous Article in Special Issue
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors
 
 
Article

Article Versions Notes

Cancers 2024, 16(14), 2493; https://doi.org/10.3390/cancers16142493
Action Date Notes Link
article xml file uploaded 9 July 2024 08:51 CEST Original file -
article xml uploaded. 9 July 2024 08:51 CEST Update https://www.mdpi.com/2072-6694/16/14/2493/xml
article pdf uploaded. 9 July 2024 08:52 CEST Version of Record https://www.mdpi.com/2072-6694/16/14/2493/pdf
article html file updated 9 July 2024 08:53 CEST Original file https://www.mdpi.com/2072-6694/16/14/2493/html
Back to TopTop